Global Medical Director

Role: Global Medical Director, Early Assets, responsible for leading medical strategy and scientific engagement for early-stage CNS programs targeting Huntington’s disease, CAA, and Alzheimer’s disease. Key responsibilities include defining global Medical Affairs strategies, influencing clinical development plans, leading scientific engagement with stakeholders, and developing evidence generation plans. The role involves serving as the medical expert, organizing expert events, and collaborating across functions such as R&D, commercial, market access, and pharmacovigilance. Qualifications: MD, PhD, PharmD, or equivalent; 5+ years in Medical Affairs or R&D with deep experience in neurological diseases; strong knowledge of regulatory, policy, and digital innovations; experience with early clinical development. High-value specifics include expertise in CNS therapeutic areas, early-stage clinical programs, and evidence planning; experience supporting global scientific congresses and stakeholder engagement is preferred. The role reports to VP, Early Assets, and requires influence, leadership presence, and strong communication skills. This is a strategic, cross-functional leadership role in a biotech focused on RNAi therapeutics, with a global scope, requiring collaboration with international stakeholders.